EP3554548A4
Noncrushable pill formulatiions
25 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6 Sheet 7 Sheet 8 Sheet 9 Sheet 10 Sheet 11 Sheet 12 Sheet 13 Sheet 14 Sheet 15 Sheet 16 Sheet 17 Sheet 18 Sheet 19 Sheet 20 Sheet 21 Sheet 22 Sheet 23 Sheet 24 Sheet 25
Every citation, both waysCites: the store holds 9 of 10
| Document | Relation | Office | Category | Cited during | Relevant claims |
|---|---|---|---|---|---|
| WO2004027045A2 | Cites | World Intellectual Property Organization (WIPO) | A | Search report | 1-16 |
| US2005119762A1 | Cites | United States of America | X | Search report | 1,4,5,16 |
| US2005272677A1 | Cites | United States of America | A | Search report | 1-16 |
| US2007123468A1 | Cites | United States of America | XI | Search report | 1-4,16 |
| US2009269405A1 | Cites | United States of America | X | Search report | 1,4,6-12,14-16 |
| US2012183948A1 | Cites | United States of America | A | Search report | 1-16 |
| US2013210854A1 | Cites | United States of America | A | Search report | 1-16 |
| WO2016115234A1 | Cites | World Intellectual Property Organization (WIPO) | X | Search report | 1,4,6-9,14-16 |
| WO2016142290A1 | Cites | World Intellectual Property Organization (WIPO) | X | Search report | 1-4,16 |
10 members in 3 offices
Priority claims19
| Document | Office | Kind | Date |
|---|---|---|---|
| 201662436147 | United States of America | P | |
| 201662436147 | United States of America | P | |
| 201662436147P | United States of America | – | |
| 201662436149 | United States of America | P | |
| 201662436149 | United States of America | P | |
| 201662436149P | United States of America | – | |
| 201762558566 | United States of America | P | |
| 201762558566 | United States of America | P | |
| 201762558566P | United States of America | – | |
| 2017067285 | United States of America | W | |
| 2017067285 | United States of America | W | |
| 201662436147P | – | – | – |
| 201662436149P | – | – | – |
| 201762558566P | – | – | – |
| US201662436147P | – | – | – |
| US201662436149P | – | – | – |
| US2017067285 | – | – | – |
| US201762558566P | – | – | – |
| WO2017US67285 | – | – | – |
Members10
| Document | Office | Kind | |
|---|---|---|---|
| WO2018118902A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO2018118903A1 | World Intellectual Property Organization (WIPO) | A1 | |
| EP3554548A1 | European Patent Office (EPO) | A1 | |
| EP3555280A1 | European Patent Office (EPO) | A1 | |
| US2020085964A1 | United States of America | A1 | |
| US2020199177A1 | United States of America | A1 | |
| EP3554548A4This record | European Patent Office (EPO) | A4 | |
| EP3555280A4 | European Patent Office (EPO) | A4 | |
| US11541125B2 | United States of America | B2 | |
| US11879019B2 | United States of America | B2 |
15 legal events, as 2 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Opt-out of the competence of the unified patent court (upc) registeredP01 | P01 | EP | |
| Supplementary search report drawn up and despatchedA4 | A4 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Amendment of ipc main classPREVIOUS MAIN CLASS: A61K0047340000R079 | R079 | DE | |
| Request for validation of the european patent (deleted)DAV | DAV | EP | |
| Request for extension of the european patent (deleted)DAX | DAX | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Request for extension of the european patentAX | AX | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: REQUEST FOR EXAMINATION WAS MADESTAA | STAA | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADESTAA | STAA | EP |
Numbers
- Publication
- 3554548
- Publication, DOCDB
- 3554548
- Publication, EPODOC
- EP3554548
- Application
- 178833810
- Application, DOCDB
- 17883381
- Application, EPODOC
- EP20170883381
Titles3
- German
- NICHT BRECHBARE TABLETTENFORMULIERUNGEN
- English
- NONCRUSHABLE PILL FORMULATIIONS
- French
- FORMULATIONS DE PILULES NON BROYABLES
Classification
- CPC, 10
- A61K47/59
- A61K47/65
- A61K9/20
- A61K47/64
- A61K47/6943
- A61K47/60
- A61K9/2036
- A61K31/485
- C12Y304/11
- C12Y304/21004
- IPC, 4
- A61K47 65
- A61K47 64
- A61K47 59
- A61K9 20
Designated states38
- Contracting states, 38
- Albania
- Austria
- Belgium
- Bulgaria
- Switzerland
- Cyprus
- Czechia
- Germany
- Denmark
- Estonia
- Spain
- Finland
- France
- United Kingdom
- Greece
- Croatia
- Hungary
- Ireland
- Iceland
- Italy
- Liechtenstein
- Lithuania
- Luxembourg
- Latvia
and 14 moreShow fewer
- Monaco
- North Macedonia
- Malta
- Netherlands (Kingdom of the)
- Norway
- Poland
- Portugal
- Romania
- Serbia
- Sweden
- Slovenia
- Slovakia
- San Marino
- Türkiye
